Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Swedbank AB

Swedbank AB cut its stake in Doximity, Inc. (NASDAQ:DOCS) by 89.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 167,882 shares of the company’s stock after selling 1,492,526 shares during the quarter. Swedbank AB owned approximately 0.09% of Doximity worth $7,315,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. LRI Investments LLC purchased a new stake in shares of Doximity during the 1st quarter worth about $27,000. Farther Finance Advisors LLC boosted its position in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares in the last quarter. Blue Trust Inc. grew its holdings in Doximity by 621.4% in the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock valued at $37,000 after purchasing an additional 1,193 shares during the period. Quarry LP increased its position in shares of Doximity by 101.2% in the second quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after buying an additional 131,253 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale purchased a new stake in shares of Doximity in the first quarter valued at approximately $46,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Up 9.8 %

NASDAQ DOCS opened at $53.54 on Wednesday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The business’s fifty day simple moving average is $44.83 and its 200-day simple moving average is $35.34. The firm has a market cap of $10.00 billion, a PE ratio of 61.54, a P/E/G ratio of 3.91 and a beta of 1.30.

Analyst Ratings Changes

DOCS has been the topic of a number of research analyst reports. The Goldman Sachs Group initiated coverage on shares of Doximity in a research note on Friday, November 15th. They issued a “neutral” rating and a $58.00 price target on the stock. Bank of America lifted their target price on shares of Doximity from $32.00 to $45.00 and gave the company a “neutral” rating in a research report on Monday, October 7th. Canaccord Genuity Group restated a “hold” rating and set a $60.00 price target (up previously from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Raymond James reaffirmed an “outperform” rating and issued a $65.00 price target (up from $37.00) on shares of Doximity in a research note on Friday, November 8th. Finally, JPMorgan Chase & Co. increased their target price on Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Eleven investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $52.27.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.